MLAB Mesa Laboratories Inc.

Mesa Labs to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

Mesa Labs to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

LAKEWOOD, Colo., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced that Gary Owens, President and CEO, and John Sakys, CFO will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14th, 2026. Management will participate in a Formal Presentation at 4:30 p.m. Pacific Time.

A live webcast of the presentation will be accessible and on the Events & Presentations section of Mesa Lab’s Investor Relations website at . An archived replay of the webcast will be available through the same link following the presentation.

About Mesa Laboratories, Inc.

Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increase patient and worker safety, and improve the quality of life throughout the world.

For more information about Mesa, please visit its website at .

Mesa Laboratories Contacts: 

Gary Owens; President and CEO,

John Sakys; CFO

1-303-987-8000





EN
19/12/2025

Underlying

MLABMesa Laboratories Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Mesa Laboratories Inc.

Jonathan Moreland
  • Jonathan Moreland
Free Trial
CSGP COSTAR GROUP IN...
XRAY DENTSPLY SIRONA... ... (+51)

InsiderInsights Weekly Report: March 14, 2026

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

CSGP COSTAR GROUP INC
XRAY DENTSPLY SIRONA INC.
WAT WATERS CORPORATION
TGL. TECNOGLASS INC.
TCBI TEXAS CAPITAL BANCSHARES INC.
SFM SPROUTS FARMERS MARKETS INC.
SFBS SERVISFIRST BANCSHARES INC
ROCK GIBRALTAR INDUSTRIES INC.
NSP INSPERITY INC.
NMFC NEW MOUNTAIN FINANCE CORPORATION
MYGN MYRIAD GENETICS INC.
MLAB MESA LABORATORIES INC.
IP INTERNATIONAL PAPER COMPANY
GOGO GOGO INC.
FFIN FIRST FINANCIAL BANKSHARES INC
COTY COTY INC. CLASS A
NXRT NEXPOINT RESIDENTIAL TRUST INC.
CRG CRH PLC
PLBC PLUMAS BANCORP
BWFG BANKWELL FINANCIAL GROUP
HOG HARLEY-DAVIDSON INC.
MPB MID PENN BANCORP INC.
SSP THE E.W. SCRIPPS COMPANY
SONO SONOS
KOS KOSMOS ENERGY LTD.
AVTR AVANTOR
AHCO INC.
CMTV ADAPTHEALTH
FOUR COMMUNITY BANCORP INC. VT
VERX SHIFT4 PAYMENTS
ADV INC.
EOSE VERTEX
CSU INC.
IMNM ADVANTAGE SOLUTIONS INC (A)
GRNT EOS ENERGY ENTERPRISES INC (A)
ACVA CAPITAL SENIOR LIVING
CPNG IMMUNOME
TKNO GRANIT SKOPKE
QSI ACV AUCTIONS INC.
TCBX COUPANG
BLCO ALPHA TEKNOVA
SMRT INC.
KRRO QUANTUM-SI INC
NCDL THIRD COAST BANCSHARES INC
FG BAUSCH + LOMB CORP
LYEL SMARTRENT INC
KORRO BIO INC
NUVEEN CHURCHILL DIRECT LENDING CORP
F AND G ANNUITIES AND LIFE
INC.
LYELL IMMUNOPHARMA INC.
03/16/26 March 16, 2026 1 EN
Free Trial
MLAB Mesa Laboratori...

Mesa Laboratories Inc Co: 3 directors

Three Directors at Mesa Laboratories Inc Co bought 6,116 shares at between 72.230USD and 76.350USD. The significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directo...

MLAB MESA LABORATORIES INC.
03/10/26 March 10, 2026 1 EN
Jonathan Moreland
  • Jonathan Moreland
Free Trial
WAT Waters Corporat...
VKTX VIKING THERAPEU... ... (+18)

InsiderInsights.com Daily Ratings Report: March 10, 2026

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

WAT WATERS CORPORATION
VKTX VIKING THERAPEUTICS
ROCK GIBRALTAR INDUSTRIES INC.
PSTG PURE STORAGE INC. CLASS A
MNKD MANNKIND CORP.
MLAB MESA LABORATORIES INC.
FSS FEDERAL SIGNAL CORPORATION
AOSL ALPHA & OMEGA SEMICONDUCTOR
EVR EVERCORE INC CLASS A
PLBC PLUMAS BANCORP
SSP THE E.W. SCRIPPS COMPANY
TCPC BLACKROCK TCP CAPITAL CORP.
EML THE EASTERN COMPANY
TSLX SIXTH STREET SPECIALTY LENDING
ADV INC.
EOSE ADVANTAGE SOLUTIONS INC (A)
BLCO EOS ENERGY ENTERPRISES INC (A)
BAUSCH + LOMB CORP
03/10/26 March 10, 2026 1 EN
 PRESS RELEASE
Free
MLAB Mesa Laboratori...

Mesa Laboratories Announces CEO Transition and Appointment of Siddhart...

Mesa Laboratories Announces CEO Transition and Appointment of Siddhartha Kadia as President and CEO LAKEWOOD, Colo., March 09, 2026 (GLOBE NEWSWIRE) --  Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa” or “the Company”), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced that Gary Owens will step down as President and CEO on April 12, 2026, and will enable a smooth leadership transition. “Gary has served as Mesa’s CEO since 2017, leading Mesa through a period of significant growth, expansion into new markets, the matu...

March 9, 2026 1 EN
 PRESS RELEASE
Free
MLAB Mesa Laboratori...

Mesa Labs Announces Third Quarter Results

Mesa Labs Announces Third Quarter Results LAKEWOOD, Colo., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa” or “the Company”), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its third fiscal quarter (“3Q26”) ended December 31, 2025 (amounts in thousands). 3Q26 Financial Summary – (comparisons are versus the same year ago period Revenues increased 3.6%Non-GAAP organic and core organic revenues1 growth was 3.6% and 1.2%, respectivelyNon-GAAP organic revenues growth exclu...

February 3, 2026 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch